Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Open-label, Phase III Trial to Assess Efficacy and Safety of Cetuximab When Given in Combination With Cisplatin Plus 5 Fluorouracil Versus Cisplatin Plus 5-fluorouracil Alone for the First-line Treatment of Chinese Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Conditions
Interventions
Cetuximab
Cisplatin/Carboplatin
+1 more
Locations
1
Germany
Research site
Darmstadt, Germany
Start Date
July 31, 2015
Primary Completion Date
January 19, 2018
Completion Date
December 20, 2021
Last Updated
May 13, 2022
NCT03485209
NCT02296684
NCT03509012
NCT02585973
NCT02822482
NCT02658214
Lead Sponsor
Merck KGaA, Darmstadt, Germany
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions